Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

Toxicology and Applied Pharmacology

Volumn 264, Issue 2, 2012, Pages 274-283

  Zhang, Leshuai W ^a   McMahon Tobin, Grainne A ^a   Rouse, Rodney L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Diabetes; Exenatide; Glucagon like peptide 1 receptor; Oleic acid; Pancreatic duct

Indexed keywords

ACETYLCYSTEINE; CHLOROQUINE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; OLEIC ACID; PROTEIN KINASE B; WORTMANNIN;

ACINAR CELL; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; IMPAIRED GLUCOSE TOLERANCE; LIPID DIET; NONHUMAN; PANCREAS CELL; PANCREAS ISLET CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; RISK FACTOR;

ACINAR CELLS; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENDOSOMES; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; ISLETS OF LANGERHANS; MICROSCOPY, CONFOCAL; OLEIC ACID; ONCOGENE PROTEIN V-AKT; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PEPTIDES; PHOSPHORYLATION; RATS; RECEPTORS, GLUCAGON; STIMULATION, CHEMICAL; VACUOLES; VENOMS;

RATTUS;

EID: 84866847934     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.08.008     Document Type: Article

References (47)

1. Blomgren K.B., Braun D., Kolterman O. Correspondence: reply to exenatide and rare adverse events. N. Engl. J. Med. 2008, 358:1971-1972. (letter).
2. Bollheimer L.C., Kestler T.M., Michel J., Buettner R., Schölmerich J., Palitzsch K.D. Intracellular depletion of insulin by oleate is due to an inhibited synthesis and not to an increased secretion. Biochem. Biophys. Res. Commun. 2001, 287(2):397-401. (Sep. 21).
3. Calvo E.L., Vaccaro M.I., Tumilasci O.R., Iovanna J.L. Synthesis and contents of pancreatic exportable enzymes. Effect of oleic acid intraduodenal administration. Acta Physiol. Pharmacol. Latinoam. 1988, 38(2):145-150.
4. Cormont M., Mari M., Galmiche A., Hofman P., Le Marchand-Brustel Y. A FYVE-finger-containing protein, Rabip4, is a Rab4 effector involved in early endosomal traffic. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(4):1637-1642. (Feb. 13, Epub 2001 Jan 30).
5. Dore D.D., Seeger J.D., Arnold Chan K. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr. Med. Res. Opin. 2009, 25(4):1019-1027. (Apr.).
6. Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. U. S. A. 1987, 84(10):3434-3438. (May).
7. Drucker D.J., Sherman S.I., Gorelick F.S., Bergenstal R.M., Sherwin R.S., Buse J.B. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care 2010, 33(2):428-433. (Feb.).
8. Elashoff M., Matveyenko A.V., Gier B., Elashoff R., Butler P.C. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology 2011, 141(1):150-156. (Jul., Epub 2011 Feb 18).
9. Eng J., Kleinman W.A., Singh L., Singh G., Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 1992, 267(11):7402-7405. (Apr. 15).
10. Gedulin B.R., Smith P., Prickett K.S., Tryon M., Barnhill S., Reynolds J., Nielsen L.L., Parkes D.G., Young A.A. Dose-reponse for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats. Diabetologia 2005, 48:1380-1385.
11. Glatz J.F., Luiken J.J., Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 2010, 90(1):367-417. (Jan., Review).
12. Grampp T., Notz V., Broll I., Fischer N., Benke D. Constitutive, agonist-accelerated, recycling and lysosomal degradation of GABA(B) receptors in cortical neurons. Mol. Cell. Neurosci. 2008, 39(4):628-637. (Dec., Epub 2008 Oct 2).
13. Grimsey N.L., Goodfellow C.E., Dragunow M., Glass M. Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway. Biochim. Biophys. Acta 2011, 1813(8):1554-1560. (Aug., Epub 2011 May 26).
14. Guillaumes S., Blanco I., Villanueva A., et al. Chloroquine stabilizes pancreatic lysosomes and improves survival of mice with diet-induced acute pancreatitis. Pancreas 1997, 14:262-266.
15. Halangk W., Lerch M.M., Brandt-Nedelev B., Roth W., Ruthenbuerger M., Reinheckel T., Domschke W., Lippert H., Peters C., Deussing J. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 2000, 106(6):773-781. (Sep.).
16. Han B., Ji B., Logsdon C.D. CCK independently activates intracellular trypsinogen and NF-kappaB in rat pancreatic acinar cells. Am. J. Physiol. Cell Physiol. 2001, 280(3):C465-C472. (Mar.).
17. Hörsch D., Göke R., Eissele R., Michel B., Göke B. Reciprocal cellular distribution of glucagon-like peptide-1 (GLP-1) immunoreactivity and GLP-1 receptor mRNA in pancreatic islets of rat. Pancreas 1997, 14(3):290-294. (Apr.).
18. Krilov L., Nguyen A., Miyazaki T., Unson C.G., Bouscarel B. Glucagon receptor recycling: role of carboxyl terminus, beta-arrestins, and cytoskeleton. Am. J. Physiol. Cell Physiol. 2008, 295(5):C1230-C1237. (Nov., Epub 2008 Sep 11).
19. Lamont B.J., Li Y., Kwan E., Brown T.J., Gaisano H., Drucker D.J. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J. Clin. Invest. 2012, 122(1):388-402. (Jan. 3, Epub 2011 Dec 19). 10.1172/JCI42497.
20. Li L., El-Kholy W., Rhodes C.J., Brubaker P.L. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 2005, 48(7):1339-1349. (Jul., Epub 2005 May 19).
21. Li H., Li H.F., Felder R.A., Periasamy A., Jose P.A. Rab4 and Rab11 coordinately regulate the recycling of angiotensin II type I receptor as demonstrated by fluorescence resonance energy transfer microscopy. J. Biomed. Opt. 2008, 13(3):031206. May-Jun.
22. Liang C., Han S., Li G., Tabas I., Tall A. Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment. Diabetes 2012, (Electronic publication ahead of print June 29, 2012). 10.2337/db11-1415.
23. Malhotra R., Singh L., Eng J., Raufman J.P. Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini. Regul. Pept. 1992, 41(2):149-156. (Sep. 22).
24. Marshall J.A., Hoag S., Shetterly S., Hamman R.F. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994, 17(1):50-56. (Jan.).
25. Matveyenko A.V., Dry S., Cox H.I., Moshtaghian A., Gurlo T., Galasso R., Butler A.E., Butler P.C. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes 2009, 58(7):1604-1615. (Jul., Epub 2009 Apr 29).
26. McGarry J.D., Dobbins R.L. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999, 42(2):128-138. (Feb., Review).
27. Nachnani J.S., Bulchandani D.G., Nookala A., Herndon B., Molteni A., Pandya P., Taylor R., Quinn T., Weide L., Alba L.M. Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia 2010, 53(1):153-159. (Jan., Epub 2009 Sep 13).
28. Oprescu A.I., Bikopoulos G., Naassan A., Allister E.M., Tang C., Park E., Uchino H., Lewis G.F., Fantus I.G., Rozakis-Adcock M., Wheeler M.B., Giacca A. Free fatty acid-induced reduction in glucose-stimulated insulin secretion: evidence for a role of oxidative stress in vitro and in vivo. Diabetes 2007, 56(12):2927-2937. (Dec., Epub 2007 Aug 23).
29. Park S., Dong X., Fisher T.L., Dunn S., Omer A.K., Weir G., White M.F. Exendin-4 uses Irs2 signaling to mediate pancreatic β cell growth and function. J. Biol. Chem. 2006, 281(2):1159-1168.
30. Reaves B.J., Bright N.A., Mullock B.M., Luzio J.P. The effect of wortmannin on the localisation of lysosomal type I integral membrane glycoproteins suggests a role for phosphoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway. J. Cell Sci. 1996, 109(Pt 4):749-762. (Apr.).
31. Roche E., Buteau J., Aniento I., Reig J.A., Soria B., Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 1999, 48(10):2007-2014. (Oct.).
32. Santos L.R., Rebelato E., Graciano M.F., Abdulkader F., Curi R., Carpinelli A.R. Oleic acid modulates metabolic substrate channeling during glucose-stimulated insulin secretion via NAD(P)H oxidase. Endocrinology 2011, 152(10):3614-3621. (Oct.).
33. Seglen P.O. Inhibitors of lysosomal function. Methods Enzymol. 1983, 96:737-764.
34. Sevillano S., De la Mano A.M., De Dios I., Ramudo L., Manso M.A. Major pathological mechanisms of acute pancreatitis are prevented by N-acetylcysteine. Digestion 2003, 68(1):34-40. (Epub 2003 Aug 29).
35. Singh V.P., Saluja A.K., Bhagat L., van Acker G.J., Song A.M., Soltoff S.P., Cantley L.C., Steer M.L. Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. J. Clin. Invest. 2001, 108(9):1387-1395. (Nov.).
36. Syme C.A., Zhang L., Bisello A. Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor. Mol. Endocrinol. 2006, 20(12):3400-3411. (Dec., Epub 2006 Aug 24).
37. Tashiro M., Nakamura H., Taguchi M., Yamaguchi T., Yoshikawa H., Fukumitsu K., Kihara Y., Otsuki M. Oleic acid-induced pancreatitis alters expression of transforming growth factor-beta1 and extracellular matrix components in rats. Pancreas 2003, 26(2):197-204. (Mar.).
38. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(18):8641-8645. (Sep. 15).
39. Tornehave D., Kristensen P., Rømer J., Knudsen L.B., Heller R.S. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J. Histochem. Cytochem. 2008, 56(9):841-851. (Sep., Epub 2008 Jun 9).
40. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995, 44(8):863-870. (Aug.).
41. van Dam R.M., Willett W.C., Rimm E.B., Stampfer M.J., Hu F.B. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002, 25(3):417-424. (Mar.).
42. Vassiliou E.K., Gonzalez A., Garcia C., Tadros J.H., Chakraborty G., Toney J.H. Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Lipids Health Dis. 2009, 8:25. (Jun. 26).
43. Wang X., Li H., De Leo D., Guo W., Koshkin V., Fantus I.G., Giacca A., Chan C.B., Der S., Wheeler M.B. Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic beta-cell line MIN6. Diabetes 2004, 53(1):129-140. (Jan.).
44. Widmann C., Dolci W., Thorens B. Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. Biochem. J. 1995, 310(Pt 1):203-214. (Aug. 15).
45. Xu G., Kaneto H., Laybutt D.R., Duvivier-Kali V.F., Trivedi N., Suzuma K., King G.L., Weir G.C., Bonner-Weir S. Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 2007, 56(6):1551-1558. (Jun., Epub 2007 Mar 14).
46. Yoshikawa H., Tajiri Y., Sako Y., Hashimoto T., Umeda F., Nawata H. Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox. Metabolism 2001, 50(5):613-618. (May).
47. Zhou J., Montrose-Rafizadeh C., Janczewski A.M., Pineyro M.A., Sollott S.J., Wang Y., Egan J.M. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells. J. Cell. Physiol. 1999, 181(3):470-478. (Dec.).